How Much Did Nova Clinical Research Raise?
Funding & Key Investors

Nova Clinical Research has solidified its market position through a strategic infusion of capital, reaching a cumulative total of $70K. This latest financial milestone, characterized by $70K in substantial expansion capital, underscores the firm's operational maturity and its capacity to scale complex clinical trial infrastructures. By securing this backing, the organization is well-positioned to enhance its research capabilities across a broad spectrum of therapeutic areas, reinforcing its role as a critical partner in the global pharmaceutical development ecosystem.

What is Nova Clinical Research?

Nova Clinical Research
Business ServicesResearch & Development

Headquartered in Bradenton, Florida, Nova Clinical Research operates as a high-capacity clinical research site, managing Phase I-IV trials with a focus on diverse medical specialties. The company maintains a robust portfolio that spans nephrology, cardiology, infectious diseases, and neurology, among other critical fields. By bridging the gap between sponsors and participants, Nova Clinical Research facilitates both investigator-initiated trials and large-scale sponsored studies. Their operational model is designed to ensure data integrity and patient safety, which are paramount in the highly regulated clinical research industry. As the demand for specialized trial sites grows, Nova Clinical Research leverages its multi-disciplinary expertise to provide comprehensive solutions that accelerate the drug development lifecycle.

How much funding has Nova Clinical Research raised?

Nova Clinical Research has raised a total of $70K across 1 funding round:

2021

Debt

$70K

Debt (2021): $70K with participation from PPP

Key Investors in Nova Clinical Research

PPP

Public-Private Partnership

What's next for Nova Clinical Research?

With the recent influx of capital, Nova Clinical Research is poised to enter a phase of aggressive operational scaling. The strategic roadmap likely involves expanding its physical footprint to accommodate a higher volume of Phase I-IV trials and investing in advanced data management technologies to streamline study execution. Furthermore, the firm is expected to deepen its expertise in high-growth therapeutic areas such as endocrinology and pulmonology, where clinical demand remains elevated. By optimizing its site-level efficiencies and strengthening its relationships with global pharmaceutical sponsors, Nova Clinical Research aims to solidify its reputation as a premier destination for complex medical research, ultimately driving long-term value for stakeholders and improving patient outcomes through accelerated medical innovation.

See full Nova Clinical Research company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesSoftware TestingProject Management
Business ServicesSoftware TestingAdvertising Networks
Business ServicesResearch & Development
Accounting for Legal PracticesBusiness Services

Frequently Asked Questions Regarding Nova Clinical Research Financial Insights

What are the most recent funding rounds that Nova Clinical Research has completed, and what were the funding rounds?
Nova Clinical Research has recently completed 1 funding rounds: Debt on Mar 13, 2021.
What is the total amount of funding Nova Clinical Research has raised to date?
Nova Clinical Research has raised a total of $70K in funding to date.
How many funding rounds has Nova Clinical Research completed?
Nova Clinical Research has completed 1 funding rounds.
How much funding did Nova Clinical Research raise in its most recent funding round?
Nova Clinical Research raised $70K in its most recent funding round.
Who are the lead investors in Nova Clinical Research's latest funding round?
The lead investor in Nova Clinical Research's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Nova Clinical Research's history?
The largest funding round in Nova Clinical Research's history was $70K.
See more information about Nova Clinical Research